M1001
M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist. M1001 can bind to the HIF-2α PAS-B domain, with a Kd of 667 nM. M1001 can be used in chronic kidney disease research[1].
Product Specifications
CAS Number
[874590-32-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HIF/HIF Prolyl-Hydroxylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/M1001.html
Purity
99.51
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=S1(C2=C(C=CC=C2)C(NC3=C(N4CCCC4)C=CC=C3)=N1)=O
Molecular Formula
C17H17N3O2S
Molecular Weight
327.40
Precautions
H302, H315, H319, H335
References & Citations
[1]Wu D, et al. Bidirectional modulation of HIF-2 activity through chemical ligands. Nat Chem Biol. 2019 Feb 25.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Streptococcus equi subsp. zooepidemicus Chorismate synthase (aroC)
Recombinant Streptococcus equi subsp. zooepidemicus Chorismate synthase (aroC)
Recombinant Streptococcus equi subsp. zooepidemicus Chorismate synthase (aroC)
Recombinant Streptococcus equi subsp. zooepidemicus Chorismate synthase (aroC)